- Supported exchanges /
- V /
- QPT.V
Quest PharmaTech Inc (QPT V) stock market data APIs
Quest PharmaTech Inc., a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. The company's lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for the potential cancer targets include pancreatic, colon, leukemia, ovarian, and breast cancer. It is also involved in the development of Oregovomab, which is in Phase III clinical trial for the treatment of ovarian cancer. The company is headquartered in Edmonton, Canada.
Quest PharmaTech Inc Financial Data Overview
| 0.42 | |
| -0.27 | |
| - | |
| -0.04 | |
| 0.26 | |
| 0.02-0.07 | |
| 5 920 K | |
| 169 M | |
| 0 | |
| 0.139 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Quest PharmaTech Inc Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA -802 410
- Earnings Per Share -0.02
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Quest PharmaTech Inc Earnings via APIs
- Latest Release 2024-09-23
- EPS/Forecast NaN
Get Quest PharmaTech Inc End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
